The Correlation and Intervention of Intestinal Flora and Frailty in the Elderly
1 other identifier
interventional
300
1 country
1
Brief Summary
The study aim to evaluate the improvement and correlation of soluble dietary fiber (prebiotics) in the frailty of elderly people by a randomized, double-blind, placebo-controlled clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2019
CompletedFirst Posted
Study publicly available on registry
June 24, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 17, 2024
July 1, 2024
5.4 years
June 10, 2019
July 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement of frailty
Frailty will be diagnosed according to Fried criteria
3 months
Secondary Outcomes (1)
Diversity analysis of intestinal flora
3 months
Study Arms (2)
exprimental: Inulin
EXPERIMENTALInulin 15 grams after dissolution by mouth, every morning for three months.
Active comparator: maltodextrin
PLACEBO COMPARATORPlacebo (maltodextrin) 15grams after dissolution by mouth, every morning for three months.
Interventions
Inulin 15 grams after dissolution by mouth, every morning for three months.
Placebo (maltodextrin) 15g/d,Oral administration after dissolution15g/d,Oral administration after dissolution
Eligibility Criteria
You may qualify if:
- Age ≥65 years;
- Can get up from a chair and walk 6 meters
- Clearly consciousness, able to read or use words to express and communicate without difficulty
- Agree and accept the study plan
You may not qualify if:
- Acute and chronic inflammatory disease of the intestine within 3 months
- Use of antibiotics, probiotics, prebiotics or synthetics, laxatives or diarrhea medications, proton pump inhibitors or gastric motility drugs within 1 month
- Dementia
- mental illness or blindness
- acute infection
- cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
Study Sites (1)
Xijing Hospital
Xi'an, Shaanxi, 710032, China
Related Publications (1)
Yang J, Hou L, Wang A, Shang L, Jia X, Xu R, Wang X. Prebiotics improve frailty status in community-dwelling older individuals in a double-blind, randomized, controlled trial. J Clin Invest. 2024 Aug 6;134(18):e176507. doi: 10.1172/JCI176507.
PMID: 39286985DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Wang xiao ming
Director of geriatrics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of geriatrics
Study Record Dates
First Submitted
June 10, 2019
First Posted
June 24, 2019
Study Start
August 1, 2019
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
July 17, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
We will not make individual participant data (IPD) available to other researchers in a few years.